Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v1-EN
Language English English
Date Updated 2021-06-08 2020-08-31
Drug Identification Number 02242367 02242367
Brand name VISUDYNE VISUDYNE
Common or Proper name verteporfin verteporfin
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients VERTEPORFIN VERTEPORFIN
Strength(s) 15MG 15MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 15ml 15ml
ATC code S01LA S01LA
ATC description OCULAR VASCULAR DISORDER AGENTS OCULAR VASCULAR DISORDER AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-10-31
Actual start date 2021-08-01
Estimated end date 2022-01-31 Unknown
Actual end date 2021-08-01
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments